statistiche ricercatore

Continente	#
NA - Nord America	1.748
AS - Asia	698
EU - Europa	489
SA - Sud America	83
Continente sconosciuto - Info sul continente non disponibili	32
AF - Africa	12
OC - Oceania	4
Totale	3.066

Nazione	#
US - Stati Uniti d'America	1.692
SG - Singapore	275
CN - Cina	138
IT - Italia	121
GB - Regno Unito	110
VN - Vietnam	89
HK - Hong Kong	83
BR - Brasile	55
SE - Svezia	52
DE - Germania	46
FI - Finlandia	39
BD - Bangladesh	26
CA - Canada	25
RU - Federazione Russa	25
FR - Francia	24
ID - Indonesia	22
NL - Olanda	21
MX - Messico	13
UA - Ucraina	13
BG - Bulgaria	11
TR - Turchia	11
IN - India	8
KR - Corea	7
AR - Argentina	6
JP - Giappone	6
CO - Colombia	5
UZ - Uzbekistan	5
AU - Australia	4
BO - Bolivia	4
EC - Ecuador	4
GR - Grecia	4
HN - Honduras	4
IQ - Iraq	4
MY - Malesia	4
VE - Venezuela	4
AE - Emirati Arabi Uniti	3
CR - Costa Rica	3
EE - Estonia	3
IE - Irlanda	3
MA - Marocco	3
PH - Filippine	3
PK - Pakistan	3
TT - Trinidad e Tobago	3
AT - Austria	2
AZ - Azerbaigian	2
BE - Belgio	2
CL - Cile	2
CW - ???statistics.table.value.countryCode.CW???	2
CZ - Repubblica Ceca	2
ES - Italia	2
GT - Guatemala	2
MD - Moldavia	2
NI - Nicaragua	2
PE - Perù	2
PL - Polonia	2
SY - Repubblica araba siriana	2
ZA - Sudafrica	2
A2 - ???statistics.table.value.countryCode.A2???	1
AO - Angola	1
CU - Cuba	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EG - Egitto	1
ET - Etiopia	1
EU - Europa	1
GE - Georgia	1
GH - Ghana	1
HU - Ungheria	1
IL - Israele	1
IR - Iran	1
JO - Giordania	1
KW - Kuwait	1
KZ - Kazakistan	1
LK - Sri Lanka	1
LT - Lituania	1
ML - Mali	1
PR - Porto Rico	1
PT - Portogallo	1
PY - Paraguay	1
RO - Romania	1
SI - Slovenia	1
TN - Tunisia	1
VG - Isole Vergini Britanniche	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	3.039

Nome	#
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study	395
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease	347
Genome-wide definition of promoter and enhancer usage during neural induction of human embryonic stem cells	329
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors	317
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID	299
Interactions between Retroviruses and the Host Cell Genome	255
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study	244
An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype	234
Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors	223
Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency	215
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia	208
Totale	3.066

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	189	0	0	0	14	5	19	8	15	26	37	35	30
2022/2023	239	36	37	11	19	31	30	5	19	24	2	9	16
2023/2024	154	6	5	15	11	31	4	9	38	4	1	4	26
2024/2025	477	8	1	2	48	102	65	22	30	70	22	41	66
2025/2026	842	48	28	42	64	161	40	120	38	109	78	59	55
2026/2027	225	29	62	46	88	0	0	0	0	0	0	0	0
Totale													3.066